Zhongguancun Group

Announcement on Litigation Involving Subsidiary Companies

Legal Opinion on the 2025 Annual Shareholders Meeting of Beijing Zhongguancun Science Technology Development (Holding) Co., Ltd.

Announcement of Shareholders' Meeting Resolutions for 2025

Announcement on Subsidiary Duoduo Pharmaceutical's Approval of Febuxostat Tablets Registration Certificate

Announcement on the Provisional Freezing of Shares by Controlling Shareholder's Concerted Actors

Announcement on Expected Major Daily Related Transactions of Duoduo Pharmaceutical for the First Half of 2026

Announcement of Resolutions from the Second Extraordinary Meeting of the 9th Board for 2026

Q1 2026 Report

Real Estate Mortgage Valuation Report

2025 Annual Board of Directors Work Report

2025 Annual Shareholders Meeting Materials

Announcement on 2025 Compensation for Directors and Senior Management and 2026 Compensation Plan

Announcement on the Reappointment of Audit Firm for 2026

2025 Annual Report of Independent Director (Xia Qin)

2025 Annual Report of Independent Director (Dong Lei Has Completed Term and Resigned)

2025 Annual Report of Independent Director (Shi Lu Wen)

2025 Annual Report of Independent Director (Bi Ke)

2025 Internal Control Audit Report

2025 Internal Control Evaluation Report

Compensation Management System for Directors and Senior Executives (April 2026)

Announcement on Asset Impairment Provisions for 2025

Announcement on Expected Daily Related Transactions for Hainan Huasu Marketing in 2026

Announcement on Company Guarantee for Duoduo Pharmaceutical's 60 Million Yuan Financing Application to CITIC Bank

Announcement on Company Guarantee for 10 Million Yuan Financing Application by Zhongshi New Materials to Bank of China

Announcement on Company Guarantee for Vodacom's 5 Million Yuan Financing Application to Bank of China

Notice of the 2025 Annual Shareholders Meeting

Announcement of Resolutions from the Fourth Meeting of the Ninth Board of Directors

Announcement on the Profit Distribution Plan for 2025

Evaluation Report on the Performance of the Accounting Firm for 2025

Report on the Audit Committee's Oversight of the Accounting Firm for 2025

Special audit report on the summary table of non-operating fund occupation and other related fund transactions for 2025

Summary of Non-Operating Fund Occupation and Other Related Fund Transactions for 2025

2025 Annual Audit Report

2025 Annual Report

Summary of the 2025 Annual Report

Announcement on Shandong Huasu Health Care Products Company Obtaining Utility Model Patent Certificate

Announcement on the Selection of Benidipine Hydrochloride Tablets for the 11th National Drug Centralized Procurement

Announcement on Continuation Procurement of Selected National Organization Drugs for Bisoprolol Fumarate Tablets

Announcement on Expiration of Judicial Re-Freeze of Shares by Controlling Shareholder and Effective Pending Freeze